ECTRIMS / EAN guideline on the pharmacological treatment of people with multiple sclerosis-Reference-Cited by-同舟云学术

ECTRIMS / EAN guideline on the pharmacological treatment of people with multiple sclerosis

Published:2018-01-19 Issue:2 Volume:25 Page:215-237
ISSN:1351-5101
Container-title:European Journal of Neurology
language:en
Short-container-title:Eur J Neurol

Author:

Montalban X.¹,Gold R.²,Thompson A. J.³,Otero‐Romero S.¹⁴^ORCID,Amato M. P.⁵,Chandraratna D.⁶,Clanet M.⁷,Comi G.⁸,Derfuss T.⁹,Fazekas F.¹⁰,Hartung H. P.¹¹,Havrdova E.¹²,Hemmer B.¹³¹⁴,Kappos L.¹⁵,Liblau R.¹⁶,Lubetzki C.¹⁷,Marcus E.¹⁸,Miller D. H.¹⁹,Olsson T.²⁰,Pilling S.¹⁸,Selmaj K.²¹,Siva A.²²,Sorensen P. S.²³,Sormani M. P.²⁴,Thalheim C.²⁵,Wiendl H.²⁶,Zipp F.²⁷

Affiliation:

1. Multiple Sclerosis Centre of Catalonia (Cemcat) Department of Neurology‐Neuroimmunology Vall d'Hebron University Hospital Barcelona Spain

2. Department of Neurology Ruhr University, St Josef‐Hospital Bochum Germany

3. Department of Brain Repair and Rehabilitation Faculty of Brain Sciences University College London Institute of Neurology London UK

4. Preventive Medicine and Epidemiology Department Vall d'Hebron University Hospital Barcelona Spain

5. Department NEUROFARBA Section Neurosciences University of Florence Florence Italy

6. Multiple Sclerosis International Federation London UK

7. Department of Neurology Toulouse University Hospital Toulouse France

8. Neurological Department Institute of Experimental Neurology (INSPE) Scientific Institute Hospital San Raffaele University Vita‐Salute San Raffaele Milan Italy

9. Departments of Neurology and Biomedicine University Hospital Basel Basel Switzerland

10. Department of Neurology Medical University of Graz Graz Austria

11. Department of Neurology Medical Faculty, Multiple Sclerosis Heinrich‐Heine‐University Düsseldorf Germany

12. Department of Neurology and Centre of Clinical Neuroscience First Faculty of Medicine and General University Hospital Charles University Prague Czech Republic

13. Department of Neurology Klinikum Rechts der Isar Technische Universität München MunichGermany

14. Munich Cluster for Systems Neurology (SyNergy) Munich Germany

15. University Hospital Basel Basel Switzerland

16. INSERM UMR U1043 – CNRS U5282 Centre de Physiopathologie de Toulouse Purpan Université de Toulouse, UPS ToulouseFrance

17. ICM‐GHU Pitié‐Salpêtrière Sorbonne Universités UPMC Univ Paris 06, UMR_S 1127 Paris France

18. Centre for Outcomes Research and Effectiveness (CORE) Research Department of Clinical, Educational and Health Psychology University College London LondonUK

19. NMR Research Unit Queen Square Multiple Sclerosis Centre University College London (UCL) Institute of Neurology London UK

20. Neuroimmunology Unit Centre for Molecular Medicine, L8:04 Karolinska University Hospital (Solna) Stockholm Sweden

21. Department of Neurology Medical University of Lodz Lodz Poland

22. Clinical Neuroimmunology Unit and MS Clinic Department of Neurology Cerrahpasa School of Medicine Istanbul University Istanbul Turkey

23. Danish Multiple Sclerosis Centre Department of Neurology Copenhagen University Hospital Rigshospitalet Copenhagen Denmark

24. Biostatistics Unit University of Genoa Genoa Italy

25. European Multiple Sclerosis Platform (EMSP) Schaerbeek/Brussels Belgium

26. Department of Neurology University of Münster MünsterGermany

27. Department of Neurology Focus Program Translational Neuroscience (FTN) and Immunology (FZI) Rhine‐Main Neuroscience Network (rmn2) University Medical Centre of the Johannes Gutenberg University Mainz Mainz Germany

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ene.13536

Reference165 articles.

1. Multiple Sclerosis

2. High incidence and increasing prevalence of multiple sclerosis in British Columbia, Canada: findings from over two decades (1991–2010)

3. A 60‐year follow‐up of the incidence and prevalence of multiple sclerosis in Hordaland County, Western Norway;Grytten N;J Neurol Neurosurg Psychiatry,2016

4. Atlas of Multiple Sclerosis 2013: A growing global problem with widespread inequity

5. New insights into the burden and costs of multiple sclerosis in Europe

Cited by 289 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aging is associated with reduced inflammatory disease activity independent of disease duration in relapsing multiple sclerosis trial populations;Multiple Sclerosis Journal;2024-09-08

2. Patient and Physician Perspectives of Treatment Burden in Multiple Sclerosis;Neurology and Therapy;2024-09-04

3. [Translated article] Risk of Skin Cancer Associated with Disease-Modifying Therapies in Multiple Sclerosis: A Comprehensive Evidence Review;Actas Dermo-Sifiliográficas;2024-09

4. Riesgo de cáncer cutáneo asociado a terapias modificadoras de la enfermedad en la esclerosis múltiple: revisión narrativa de la evidencia actual;Actas Dermo-Sifiliográficas;2024-09

5. Disease modifying treatment guidelines for multiple sclerosis in the United Arab Emirates;Multiple Sclerosis and Related Disorders;2024-08